JP2004516236A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2004516236A5 JP2004516236A5 JP2001583806A JP2001583806A JP2004516236A5 JP 2004516236 A5 JP2004516236 A5 JP 2004516236A5 JP 2001583806 A JP2001583806 A JP 2001583806A JP 2001583806 A JP2001583806 A JP 2001583806A JP 2004516236 A5 JP2004516236 A5 JP 2004516236A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutical composition
- antibody
- composition according
- factor
- antibody fragment
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US57143400A | 2000-05-15 | 2000-05-15 | |
| PCT/US2000/027438 WO2001087339A1 (en) | 2000-05-15 | 2000-10-05 | Antithrombotic agents |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2004516236A JP2004516236A (ja) | 2004-06-03 |
| JP2004516236A5 true JP2004516236A5 (https=) | 2007-11-22 |
Family
ID=24283688
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2001583806A Pending JP2004516236A (ja) | 2000-05-15 | 2000-10-05 | 抗血栓剤 |
Country Status (20)
| Country | Link |
|---|---|
| US (1) | US20050037006A1 (https=) |
| EP (2) | EP1282444B1 (https=) |
| JP (1) | JP2004516236A (https=) |
| KR (2) | KR20070116192A (https=) |
| CN (2) | CN100339132C (https=) |
| AT (1) | ATE345816T1 (https=) |
| AU (2) | AU2000278584B2 (https=) |
| BR (1) | BR0015872A (https=) |
| CA (1) | CA2411369A1 (https=) |
| CZ (1) | CZ20023778A3 (https=) |
| DE (1) | DE60032029T2 (https=) |
| ES (1) | ES2277597T3 (https=) |
| HU (1) | HU225874B1 (https=) |
| IL (1) | IL152831A0 (https=) |
| MX (1) | MXPA02011385A (https=) |
| NO (1) | NO20025463L (https=) |
| NZ (1) | NZ522632A (https=) |
| PL (1) | PL360060A1 (https=) |
| WO (1) | WO2001087339A1 (https=) |
| ZA (1) | ZA200209265B (https=) |
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8980952B2 (en) | 2002-03-20 | 2015-03-17 | University Of Maryland, Baltimore | Methods for treating brain swelling with a compound that blocks a non-selective cation channel |
| EP2438913B1 (en) | 2002-03-20 | 2020-05-06 | University of Maryland, Baltimore | A non-selective cation channel in neural cells and compounds that block the channel for use in treating brain swelling |
| AU2005287090A1 (en) | 2004-09-18 | 2006-03-30 | Department Of Veterans Affairs | Therapeutic agents targeting the NCca-ATP channel and methods of use thereof |
| JP5307397B2 (ja) | 2004-09-18 | 2013-10-02 | ユニバーシティ オブ メリーランド，ボルチモア | ＮＣＣａ−ＡＴＰチャネルを標的とする治療剤およびその使用方法 |
| US9511075B2 (en) | 2007-01-12 | 2016-12-06 | The University Of Maryland, Baltimore | Targeting NCCA-ATP channel for organ protection following ischemic episode |
| WO2009002832A2 (en) | 2007-06-22 | 2008-12-31 | University Of Maryland, Baltimore | Inhibitors of ncca-atp channels for therapy |
| CN101874042B9 (zh) | 2007-09-26 | 2019-01-01 | 中外制药株式会社 | 利用cdr的氨基酸取代来改变抗体等电点的方法 |
| PT3002298T (pt) * | 2007-11-21 | 2019-11-20 | Univ Oregon Health & Science | Anticorpos monoclonais anti-fator xi e métodos de utilização dos mesmos |
| GB201121513D0 (en) * | 2011-12-14 | 2012-01-25 | Cambridge Entpr Ltd | Thrombin-binding antibody molecules and uses thereof |
| US9518128B2 (en) | 2011-12-14 | 2016-12-13 | Janssen Pharmaceuticals, Inc. | Thrombin-binding antibody molecules |
| CN110325211A (zh) * | 2016-12-23 | 2019-10-11 | 诺华股份有限公司 | 采用抗因子XI/XIa抗体治疗的方法 |
| US20200109390A1 (en) | 2017-04-27 | 2020-04-09 | Chugai Seiyaku Kabushiki Kaisha | Coagulation factor ix with improved pharmacokinetics |
| US20240018503A1 (en) * | 2017-04-27 | 2024-01-18 | Chugai Seiyaku Kabushiki Kaisha | Coagulation factor ix with improved pharmacokinetics |
| CN115448985A (zh) * | 2021-06-08 | 2022-12-09 | 上海循曜生物科技有限公司 | 新型抗栓抗体 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2049655C (en) * | 1990-09-17 | 1996-11-12 | Akio Odawara | Pharmaceutical composition for inhibiting platelet aggregation |
| MA24512A1 (fr) * | 1996-01-17 | 1998-12-31 | Univ Vermont And State Agrienl | Procede pour la preparation d'agents anticoagulants utiles dans le traitement de la thrombose |
| WO2000007626A1 (en) * | 1998-08-07 | 2000-02-17 | Smithkline Beecham Corporation | Use of anti-coagulation factor antibodies as long-lasting protective agents |
| BR9913435A (pt) * | 1998-08-28 | 2001-09-25 | Genentech Inc | Composições compreendendo anticorpos anti-fator ix/ixa humanos, ácido nucléico isolado, vetor, célula hospedeira, método de produção de anticorpo ou fragmento de anticorpo, artigo industrializado, método de tratamento de um mamìfero e composição farmacêutica |
-
2000
- 2000-10-05 BR BR0015872-0A patent/BR0015872A/pt not_active IP Right Cessation
- 2000-10-05 NZ NZ522632A patent/NZ522632A/en unknown
- 2000-10-05 AT AT00968710T patent/ATE345816T1/de not_active IP Right Cessation
- 2000-10-05 AU AU2000278584A patent/AU2000278584B2/en not_active Ceased
- 2000-10-05 IL IL15283100A patent/IL152831A0/xx unknown
- 2000-10-05 WO PCT/US2000/027438 patent/WO2001087339A1/en not_active Ceased
- 2000-10-05 EP EP00968710A patent/EP1282444B1/en not_active Expired - Lifetime
- 2000-10-05 CN CNB008197237A patent/CN100339132C/zh not_active Expired - Fee Related
- 2000-10-05 DE DE60032029T patent/DE60032029T2/de not_active Expired - Fee Related
- 2000-10-05 CN CNA200710141110XA patent/CN101134107A/zh active Pending
- 2000-10-05 PL PL36006000A patent/PL360060A1/xx unknown
- 2000-10-05 KR KR1020077027348A patent/KR20070116192A/ko not_active Ceased
- 2000-10-05 JP JP2001583806A patent/JP2004516236A/ja active Pending
- 2000-10-05 CA CA002411369A patent/CA2411369A1/en not_active Abandoned
- 2000-10-05 KR KR1020027015403A patent/KR20030034071A/ko not_active Ceased
- 2000-10-05 MX MXPA02011385A patent/MXPA02011385A/es active IP Right Grant
- 2000-10-05 EP EP06124420A patent/EP1825864A3/en active Pending
- 2000-10-05 AU AU7858400A patent/AU7858400A/xx active Pending
- 2000-10-05 HU HU0301804A patent/HU225874B1/hu not_active IP Right Cessation
- 2000-10-05 CZ CZ20023778A patent/CZ20023778A3/cs unknown
- 2000-10-05 ES ES00968710T patent/ES2277597T3/es not_active Expired - Lifetime
-
2002
- 2002-11-14 NO NO20025463A patent/NO20025463L/no not_active Application Discontinuation
- 2002-11-14 ZA ZA200209265A patent/ZA200209265B/xx unknown
-
2003
- 2003-08-11 US US10/638,777 patent/US20050037006A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2004516236A5 (https=) | ||
| LU92255I2 (fr) | Ocriplasmine et ses dérivés pharmaceutiquement acceptables (JETREA) | |
| Lijnen et al. | Fibrinolytic agents: mechanisms of activity and pharmacology | |
| IL215891A (en) | Hepatitis C Serine Protease Inhibitors, Pharmaceutical Compounds Containing Them, and Their Use in Preparing Drugs to Treat Hepatitis C Infections | |
| MY129356A (en) | Electrospun pharmaceutical compositions | |
| WO2002095007A3 (en) | Conjugates activated by cell surface proteases and therapeutic uses thereof | |
| MXPA04005755A (es) | Combinacion de inhibidores de proteasa dependientes del citocromo p450. | |
| AU6379101A (en) | Highly selective inhibitors of the urokinase plasminogen activator | |
| WO2001068645A3 (en) | N-cyanomethylcarboxamides and their use as protease inhibitors | |
| EP1825864A3 (en) | Antithrombotic agents | |
| WO2003008637A3 (en) | Use of genotyping in the individualization of therapy | |
| PT1227797E (pt) | Formulacoes farmaceuticas de dispersao solida | |
| WO2002022107A3 (en) | Pharmaceutical composition having modified carrier | |
| SE0000303D0 (sv) | Novel compounds | |
| WO2003053999A3 (de) | Selektive arylguanidinpeptide als urokinaseinhibitoren | |
| CA2007075A1 (en) | New thrombolytic compositions | |
| BRPI0317780B8 (pt) | uso de supositório de estreptoquinase com ação trombolítica | |
| Thomson | New thrombolytic drugs | |
| EP1232755A3 (en) | Anti-HIV agents | |
| MY120631A (en) | Novel pharmaceutical combination having analgesic activity | |
| JP2001521898A5 (ja) | 心筋虚血およびアンギナの処置用医薬の製造のためのキナプリルの使用 |